Profiel
Julien Höfer is currently the Managing Director at Apeiron Investment Group Ltd. and a Member-Supervisory Board at ATAI Life Sciences AG.
He completed his undergraduate degree at Freie Universität Berlin in 2013 and his graduate degree at the University of Malta in 2020.
Actieve functies van Julien Höfer
| Bedrijven | Functie | Begin |
|---|---|---|
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in development of pharmaceuticals for mental health treatment | Directeur/Bestuurslid | - |
Apeiron Investment Group Ltd. /Private Equity/
Apeiron Investment Group Ltd. /Private Equity/ Investment ManagersFinance Apeiron Partners invests in companies located in the United States, United Kingdom and Europe. The firm focuses on a broad range of sectors and industries. It participates in seed, early and growth stage capital requirements. | Private Equity Investor | 01-01-2019 |
Opleiding van Julien Höfer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Malta
University of Malta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in development of pharmaceuticals for mental health treatment | Health Technology |
Apeiron Investment Group Ltd. /Private Equity/
Apeiron Investment Group Ltd. /Private Equity/ Investment ManagersFinance Apeiron Partners invests in companies located in the United States, United Kingdom and Europe. The firm focuses on a broad range of sectors and industries. It participates in seed, early and growth stage capital requirements. | Finance |
















